NCT06222333

Brief Summary

Respiratory physiotherapy is routinely performed after thoracic surgery operations to increase lung expansion and prevent pulmonary complications such as atelectasis and pneumonia. It is a controversial issue whether respiratory physiotherapy reduces pulmonary complications in rib fractures. In our study, patients with rib fractures will be divided into two groups. In the control group, standard treatment consisting of routine analgesic treatments will be applied. In the other group, respiratory physiotherapy will be applied with triflu for 8 hours a day. At the end of the study, pulmonary complications in both groups will be compared.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 3, 2024

Completed
21 days until next milestone

First Posted

Study publicly available on registry

January 24, 2024

Completed
10 months until next milestone

Study Start

First participant enrolled

November 13, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

November 14, 2024

Status Verified

November 1, 2024

Enrollment Period

5 months

First QC Date

January 3, 2024

Last Update Submit

November 13, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • FEV1, FVC, FEV1/FVC results on day 7

    FEV1, FVC, FEV1/FVC

    7 days

Secondary Outcomes (2)

  • Number of Participants with Pneumonia

    7 days

  • FEV1, FVC, FEV1/FVC results on day 2

    2 days

Study Arms (2)

Respiratory physiotherapy group

EXPERIMENTAL

In this group of patients, in addition to routine analgesic treatment, triflow use and deep breathing training would be given by the physiotherapist. Patients in this group will do breathing exercises 8 hours a day, 10 times an hour

Behavioral: Respiratory physiotherapy

Routine treatment group

ACTIVE COMPARATOR

Patients in the control group will receive conservative treatment consisting of paracetamol and dexketoprofen.

Drug: Conservative Treatment

Interventions

In this group of patients, in addition to routine analgesic treatment, triflow use and deep breathing training would be given by the physiotherapist. Patients in this group will do breathing exercises 8 hours a day, 10 times an hour.

Also known as: Triflow
Respiratory physiotherapy group

Patients in the control group will receive conservative treatment consisting of paracetamol and dexketoprofen.

Also known as: Control
Routine treatment group

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Isolated thoracic injury within 24 hours
  • Age between 18-100

You may not qualify if:

  • Pneumothorax and hemothorax requiring intervention at admission
  • Injury severity index \>16
  • COPD, Atshma
  • Extrathoracic trauma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kastamonu University

Kastamonu, 37150, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Rib Fractures

Interventions

Conservative Treatment

Condition Hierarchy (Ancestors)

Fractures, BoneWounds and InjuriesThoracic Injuries

Intervention Hierarchy (Ancestors)

Therapeutics

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor Literally: Doctor Teaching Member

Study Record Dates

First Submitted

January 3, 2024

First Posted

January 24, 2024

Study Start

November 13, 2024

Primary Completion

April 1, 2025

Study Completion

April 1, 2026

Last Updated

November 14, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will share

Yes

Time Frame
Data will be available permanently on 1.4.2025
Access Criteria
Upon reasonable request principal investigator will share date

Locations